Viewing Study NCT02473367


Ignite Creation Date: 2025-12-25 @ 12:26 AM
Ignite Modification Date: 2026-01-06 @ 1:44 AM
Study NCT ID: NCT02473367
Status: COMPLETED
Last Update Posted: 2018-08-27
First Post: 2015-06-12
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: The Effect of Antacids on the Pharmacokinetics (PK) of Raltegravir in Human Immunodeficiency Virus (HIV)-Infected Participants (MK-0518-824)
Sponsor: Merck Sharp & Dohme LLC
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2015-06-23
Start Date Type: ACTUAL
Primary Completion Date: 2015-08-29
Primary Completion Date Type: ACTUAL
Completion Date: 2015-10-09
Completion Date Type: ACTUAL
First Submit Date: 2015-06-12
First Submit QC Date: None
Study First Post Date: 2015-06-16
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2016-07-19
Results First Submit QC Date: None
Results First Post Date: 2016-09-01
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2018-07-27
Last Update Post Date: 2018-08-27
Last Update Post Date Type: ACTUAL